Expanded Access: FDA Describes Efforts to Ease Application Process

By: Scott Gottlieb, M.D. FDA has a long history of supporting patient access to investigational new treatments. This includes working with drug and device companies through the clinical trial process that may lead to FDA approval of the treatment. We … Continue reading →